4th ACDM AI Symposium with QFINITY

On June 23–24, 2025, Marcus Schwabedissen, COO of QFINITY, will participate in the 4th ACDM AI Symposium in Frankfurt. This event brings together international experts in the field of clinical data science to discuss current developments, practical applications, and the regulatory and ethical challenges of using artificial intelligence (AI) in clinical research.

As a long-standing active member of the ACDM and a member of the Steering Committee, Marcus Schwabedissen plays a key role in shaping the strategic direction of the symposium. With his extensive experience in optimizing clinical data management processes and implementing innovative technologies, he provides valuable input for a quality-driven and future-oriented use of AI in data-driven healthcare.

His participation highlights QFINITY’s ongoing commitment to innovation, quality, and practical advancement in clinical research.

More information about the 4th ACDM AI Symposium can be found here.